Skip to main content
. 2012 Dec 12;14(3):185–192.

Fig 2.

Fig 2

Experimental design for MDMA treatment (A). Embryonic stem cells (ESCs) were treated either with MDMA throughout the process of neural differentiation (group 1), or only during post-plating (group 2). B and C show semi-quantitative RT-PCR analyses of MDMA on the relative gene expression of metabotropic glutamate receptor 5 (mGlu5) in groups 1 (B) and 2 (C).

a; P<0.002 for controls and 10 µM vs. 100 µM.